PrimeRFP SCOUT · Federal Contract Recompete Brief

W81XWH22F000515043761 MISEQ reagent KT QTY 229 — Verogen, Inc

The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Dec 30, 2021 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

W4pz Usa Med Rsch Acquis Act

Awarding office

Verogen, Inc

Recipient

Dec 30, 2021

PoP end

$300K

Obligated

$300K

Potential

334516

NAICS

6640

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Verogen, Inc — $90

Contract facts

NONE

Contract numberW81XWH22F0005

Also listed asW81XWH-22-F-0005

Also listed asW81XWH19A0002-W81XWH22F0005

AgencyW4pz Usa Med Rsch Acquis Act

Awarding officeW4pz Usa Med Rsch Acquis Act

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentVerogen, Inc

CAGE803G9

UEIN2ASZNFB5EV5

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640

Parent IDIQ / IDVW81XWH19A0002

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitationW81XWH18R0059

PoP startNov 29, 2021

PoP end (current)Dec 30, 2021

Obligated$300K

Current value$300K

Potential value$300K

15043761 MISEQ REAGENT KT QTY 229 is a federal NONE award for W4pz Usa Med Rsch Acquis Act held by Verogen, Inc. Estimated value $300K ($300K obligated). Current period of performance ends Dec 30, 2021. Last award drew 1 bidder. Place of performance: SAN DIEGO CA. Related solicitation W81XWH18R0059.

Recompete timing

Public

● Past PoP end (1695 days ago)

Current PoP ended Dec 30, 2021 (1695 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81XWH22F0005?

W81XWH22F0005 (15043761 MISEQ reagent KT QTY 229) is a W4pz Usa Med Rsch Acquis Act award with a potential value of $300K, currently held by Verogen, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81XWH-22-F-0005?

W81XWH-22-F-0005 is the dashed form of PIID W81XWH22F0005 (15043761 MISEQ reagent KT QTY 229), held by Verogen, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81XWH22F0005?

W4pz Usa Med Rsch Acquis Act awarded W81XWH22F0005 to Verogen, Inc (potential $300K).

Who is the incumbent on W81XWH22F0005?

Verogen, Inc is the incumbent. The current period of performance ends Dec 30, 2021.

When does Verogen, Inc’s W81XWH22F0005 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 30, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Dec 1, 2023 · refreshed monthly